tiprankstipranks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Nuvectis Pharma (NVCT) Financial Statements

51 Followers

Nuvectis Pharma Financial Overview

Nuvectis Pharma's market cap is currently ―. The company's EPS TTM is $-1.373; its P/E ratio is -4.89; Nuvectis Pharma is scheduled to report earnings on August 2, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-$ -3.50M---
EBIT$ -4.40M$ -6.87M$ -6.16M$ -5.77M$ -4.10M
EBITDA$ -4.40M$ -6.87M-$ -5.77M$ -4.10M
Net Income Common Stockholders$ -4.17M$ -6.62M$ -5.88M$ -5.71M$ -4.05M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.50M$ 19.10M$ 22.10M$ 24.60M$ 15.50M
Total Assets$ 19.71M$ 19.18M$ 22.26M$ 24.94M$ 16.24M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -19.50M$ -19.10M$ -22.10M$ -24.60M$ -15.50M
Total Liabilities$ 5.69M$ 6.98M$ 5.58M$ 4.61M$ 3.93M
Stockholders Equity$ 14.02M$ 12.20M$ 16.69M$ 20.37M$ 12.31M
Cash Flow-
Free Cash Flow$ -4.36M$ -3.85M-$ -4.08M$ -4.78M
Operating Cash Flow$ -4.36M$ -3.85M$ -3.24M$ -4.08M$ -4.78M
Investing Cash Flow-----
Financing Cash Flow$ 4.70M$ 917.00K$ 703.00K$ 13.21M$ 252.00K
Currency in USD

Nuvectis Pharma Earnings and Revenue History

Nuvectis Pharma Debt to Assets

Nuvectis Pharma Cash Flow

Nuvectis Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis